5 MINUTES CAN CHANGE YOUR LIFE.
What is TD?
TD is a movement disorder that can develop in individuals who take certain medications, especially those used to treat mental health conditions, for an extended period. It manifests as involuntary and often repetitive movements in different parts of the body.
If you've noticed any of the following, it's important to seek professional guidance:
- Facial movements: Blinking excessively, grimacing, puckering lips, sticking out tongue
- Body movements: Jerking or twitching of arms, legs, or torso
- Other: Restlessness, difficulty staying still
Tardive Dyskinesia Treatment
There are two FDA-approved brand-name drugs that can treat tardive dyskinesia: Ingrezza (valbenazine) and Austedo (deutetrabenazine). You can talk to your doctor about taking these treatments alongside your current mental health treatment.
Understanding the Causes
While the exact cause of TD remains under investigation, research suggests a strong link between certain medications and its development. The risk of developing TD increases the longer a person takes these medications.
Medications associated with TD:
- Antipsychotics: These medications are primarily used to treat mental health conditions like schizophrenia, bipolar disorder, and some severe depression cases. Antipsychotics such as Haloperidol (Haldol) Fluphenazine Risperidone (Risperdal) and Olanzapine (Zyprexa).
- Tricyclic antidepressants: Though less commonly used, some tricyclic antidepressants, such as Amitriptyline and Trazodone have also been linked to TD.
- Antiemetics: Certain medications used to manage nausea and vomiting, like metoclopramide or Compro (prochlorperazine) carry a risk of TD, especially with prolonged use.
up to
1 in 4
in as early as
3 months
Early evaluation and treatment are crucial
Only a medical professional can diagnose TD. If you suspect you might have it, click below to complete a TDScreen and get results you can share with your healthcare provider. Please do not start or stop any medications or treatment plans without consulting with your provider.
How TDScreen Works
The TDScreen tool is based on the Abnormal Involuntary Movement Scale (AIMS), a comprehensive clinician-rated scale designed to specifically evaluate orofacial movements. Employing advanced AI video technology, TDScreen efficiently assesses and quantifies the risk of tardive dyskinesia in less than 5 minutes. The resulting score generated by this assessment can be communicated with your healthcare provider to aid in clinical decision-making and management strategies.
Welcome to TDScreen
TDScreen estimates your risk for TD and share results with your provider
This is for YOU
TDScreen was made with you in mind. It’s simple and takes less than 5 minutes.
Let’s talk about video
To see your movements, you will be asked to record short video responses. It’s easy!
For Providers
Elevate patient care effortlessly with TDScreen.
1 in 4 patients who have been prescribed antipsychotics are at risk of TD, which if caught early, can be treatable. TDScreen is a seamless solution for psychiatric providers seeking to enhance patient care.
With TDScreen, your patients on antipsychotics can easily and naturally complete virtual screenings in their own environments to accurately assess their risk factors and to enable you to monitor or modify their treatment plans.
Effortlessly enroll patient cohorts receiving antipsychotics for automated TDScreen assessments at predetermined intervals, ensuring proactive healthcare management.
Our intuitive interface simplifies scheduling tailored screening and monitoring protocols, accompanied by automated reminders and notifications to keep both providers and patients engaged every step of the way.
For Providers
Elevate patient care effortlessly with TDScreen.
1 in 4 patients who have been prescribed antipsychotics are at risk of TD, which if caught early, can be treatable. TDScreen is a seamless solution for psychiatric providers seeking to enhance patient care.
With TDScreen, your patients on antipsychotics can easily and naturally complete virtual screenings in their own environments to accurately assess their risk factors and to enable you to monitor or modify their treatment plans.
Effortlessly enroll patient cohorts receiving antipsychotics for automated TDScreen assessments at predetermined intervals, ensuring proactive healthcare management.
Our intuitive interface simplifies scheduling tailored screening and monitoring protocols, accompanied by automated reminders and notifications to keep both providers and patients engaged every step of the way.
Start Screening your Patients Today with TDScreen
Clinicians can now access our FREE online platform, TDScreen, designed to streamline TD risk assessment and improve patient care.
Seamlessly integrate automated TDScreen protocols alongside other essential screening and monitoring programs (additional fees may apply).
Join us today to scale patient care and improve health outcomes effortlessly.
I Want Early Access
The next generation of measured-based patient care — powered by video, text and audio.
Disclaimer: TDScreen is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Its intended use is to provide a preliminary estimate of the potential risk for Tardive Dyskinesia for people currently taking or have taken Neuroleptic medications (also known as anti-psychotics). Other potential causes of tardive dyskinesia include certain anti-depressants and mood stabilizers, certain anti-nausea medications, certain anti-seizure medications, decongestants such as pseudoephedrine and phenylephrine, medications for movement disorders. People who have been diagnosed with Parkinson’s, Huntington’s, or any other movement disorder should not use TDScreen. The results generated by this screener do not constitute medical advice or a diagnosis and should not be used as a basis for self-diagnosis or self-treatment. Any reliance on the results of this screener should be accompanied by seeking guidance from a qualified healthcare professional for a comprehensive evaluation and diagnosis. If you are experiencing symptoms or concerns related to Tardive Dyskinesia or any other medical condition, please consult with a licensed medical professional for appropriate assessment and care. Only available in the United States.
© 2024 Videra Health, Inc. All rights reserved. Stock photos used.